Salute e Benessere

Notice to attend the annual general meeting in SciBase Holding AB (publ)

Shareholders wishing to participate at the meeting must: Shareholders wishing to participate at the meeting must: Notification shall include full name, personal identification number or corporate registration number, address, daytime telephone number and, if appropriate, information about representative, proxy, and assistants. The number of assistants may not be more than two. In order to facilitate entry to the meeting, notification should, where appropriate, be ac-companied by powers of...
PR Newswire
13/05/2024

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active…

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer's disease progressionAC Immune to receive upfront payment of $100 million upon closing and be eligible for an option exercise fee and additional potential milestones of up to approximately...
Nasdaq GlobeNewswire
13/05/2024

Global Action to End Smoking, Formerly Foundation for a Smoke-Free World, Awards…

"We're thrilled to work with the experts at the Urban Institute, who will carry out the important work of quantifying the magnitude of the problem of the smoking epidemic among low-income individuals in the U.S.," said Cliff Douglas, President of Global Action to End Smoking. "Understanding the barriers to cessation is the first step to overcoming them. This work reflects our commitment to end the smoking epidemic worldwide by helping us better understand how best to empower those…
PR Newswire
13/05/2024

The Official Cooperation Launched Between HONGQI & Two Renowned Brands ---- The…

HONGQI has also entered into a Memorandum of Understanding (MOU) with Nervora & Vogue Arabia to leverage their upscale resources in the Middle East, enriching the user experience with innovation and sophistication. This cooperation aims to elevate the profile of the HONGQI brand and its vehicles, bolstering brand recognition and perception. Through increased exposure, HONGQI seeks to align its brand and products with notions of fashion, luxury, and global allure. Previously, HONGQI EHS9 and…
PR Newswire
13/05/2024

Hummingbird Bioscience Presents New Preclinical Data Highlighting…

Data highlights potential of Hummingbird Bioscience's dual-payload antibody-drug conjugate platform to improve upon the current generation of ADCs SAN FRANCISCO and SINGAPORE, May13, 2024(GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced two presentations at the 20 thAnnual PEGS Boston summit being held from May 13-17, 2024. Data from the first presentation...
Nasdaq GlobeNewswire
13/05/2024

Notification of managers' transactions

ANNOUNCEMENT NO. 263 Notification of managers' transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.See the transactions of CEO Martin Helbo Behrens in the attached PDF document.For further information, please contact:Niels Høy Nielsen, CFO...
Nasdaq GlobeNewswire
13/05/2024

Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)

The general meeting resolved, in accordance with the board of directors' three proposals, to amend §§ 4-5 of the articles of association, entailing: The general meeting resolved, in accordance with the board of directors' three proposals, to amend §§ 4-5 of the articles of association, entailing: The general meeting further resolved, in a accordance with the board of directors' proposal, to authorize the board of directors to register with the Swedish Companies Registration Office the above...
PR Newswire
13/05/2024

Ecolab and HeiQ introduce synbiotic cleaning products at Interclean

Harnessing the power of pre- and probiotics, the 50 billion probiotics per liter of Maxx Synbiotic deliver immediate, continuous, and microscopic-level cleaning, highly efficient odor reduction, long-lasting efficacy, and support for a well-balanced microbiome on surfaces. HeiQ's synbiotic cleaning technology was validated in several scientific studies, e.g. the landmark study published in May 2023 in The Lancet by renowned Charité University Hospital Berlin. Harnessing the power of pre- and...
PR Newswire
13/05/2024

Dental Polishing Machine Market to Reach $6.5 Billion Globally by 2032 at 6.1%…

Request Sample of the Report on Dental Polishing Machine Market Forecast - https://www.alliedmarketresearch.com/request-sample/A200170 Request Sample of the Report on Dental Polishing Machine Market Forecast -https://www.alliedmarketresearch.com/request-sample/A200170 Prime Determinants of Growth The rising prevalence of dental diseases, the growing emphasis on aesthetic dentistry, and the growing awareness about oral health services are the factors expected to drive the growth...
PR Newswire
13/05/2024

Inventiva announces the publication in Nature Communications of additional…

Improvements were observed for insulin resistance (insulin levels, HOMA-IR), lipid metabolism (triglycerides, HDL-cholesterol, apolipoproteins), control of glycemia (HbA1c, fasting glucose (FG) levels), systemic inflammation (hs-CRP, ferritin), hepatic steatosis and diastolic blood pressure.Among the patients who had prediabetes at study entry and were treated with lanifibranor, the majority had fasting glucose levels within the normal range at the end of treatment. No patient treated with...
Nasdaq GlobeNewswire
13/05/2024

MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates…

MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion StrategyOn track to file IND in mid-2025 for a Phase 2b clinical trial in Hidradenitis Suppurativa (“HS”) with MC2-32, a first-in-class, oral drug candidate targeting pathways involved in numerous Immunology and Inflammation indications (“I&I")Comprehensive pre-clinical studies show that MC2-32 is highly relevant for neutrophilic dermatoses as well as other I&I...
Nasdaq GlobeNewswire
13/05/2024

New Research from Self Tan Brand Vita Liberata for Skin Cancer Awareness Month…

Willing to Take the Health Risk. Of 1000 women surveyed: Willing to Take the Health Risk. Of 1000 women surveyed: - 1 in 3 use tanning beds and will continue to despite health risks - 91% are aware of the health risks - Almost half (48%) say sunbeds are addictive Beyond a Tan. The Perceived Benefits by Sunbed Users: - 57% of women said the tan is their primary reason for enjoying a sunbed session - 1-in-3 say they use sunbeds for body confidence - A fifth say...
PR Newswire
13/05/2024

Groupe Casino: Sale of GreenYellow

Sale of GreenYellow Paris, 13 May 2024The Casino Group announces that it has reached an agreement with Ardian and Bpifrance to sell its 10.15% stake in GreenYellow. As an essential and decisive condition of this transaction, all amounts owed between the Casino Group and GreenYellow, resulting notably from the sale of hypermarkets and supermarkets to Groupement Les Mousquetaires and Auchan, which had been authorized under the accelerated safeguard procedure, will be settled.The net...
Nasdaq GlobeNewswire
13/05/2024

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk…

The opening ceremony featured BGI Group CEO and BGI Genomics Vice Chairman Yin Ye, BGI Genomics Vice President Li Zhiping, and BGI Genomics Northeast Region General Manager Su Hang, along with Heilongjiang Longwei Precision Medicine Laboratory Chairman Jia Lipeng. The opening ceremony featured BGI Group CEO and BGI Genomics Vice ChairmanYin Ye, BGI Genomics Vice President Li Zhiping, and BGI Genomics Northeast Region General ManagerSu Hang, along with Heilongjiang Longwei Precision...
PR Newswire
13/05/2024

XRP Healthcare Solidifies Presence in Uganda with Trademark Registration Success

The registration of the XRP Healthcare trademark serves as a necessary prerequisite for the company to create its brand of pharmacies, medical centres, and hospitals inUganda. This strategic move underscores XRP Healthcare's commitment to not only expand its footprint, but also to enhance the quality and accessibility of healthcare services through its proprietary establishments. This intentional manoeuvre is indicative of XRP Healthcare's steadfast focus on establishing a robust...
PR Newswire
13/05/2024

Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion…

Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereigntyParis, May 13, 2024. As the largest private contributor to the security and independence of France's health ecosystem,Sanofi today announces an investment of more than €1 billion to create new bioproduction capacityat its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) and Lyon Gerland (Rhône). This new investment will...
Nasdaq GlobeNewswire
13/05/2024

Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its…

Results Intended to Support Filing for Potential Label Extension for Use in AdolescentsSaint-Herblain (France), May 13, 2024–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive pivotal Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine. Following the initial analysis up to Day 29 post-vaccination, the most recent analysis of study VLA1553-321 evaluated the safety and immunogenicity six months...
Nasdaq GlobeNewswire
13/05/2024

Introducing PBC BioVet: A New Frontier in Veterinary Healthcare

The creation of PBC BioVet marks a pivotal moment in our company's journey. Leveraging decades of expertise in biomedical innovation, PBC Biomed is expanding its horizons to address the unique needs of our beloved animal companions. By establishing PBC BioVet, we are reaffirming our dedication to advancing healthcare across species boundaries."At PBC Biomed, we recognize the profound bond between humans and animals, and we believe that every creature deserves access to high-quality...
Nasdaq GlobeNewswire
13/05/2024

TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials…

TrialWire™Rapid Patient Recruitment Platform, the only pay-per-enrolled fixed-fee solution powered by AI and algorithms, has been selected as a finalist by Citeline in three key categories: Best use of artificial intelligence in clinical trialsBest patient-facing technology initiativeBest sponsor-facing technology initiativeTry pay-per-enrollment starts in 24 hours TrialWire™ not only finds highly eligible patients on time but also reduces patient communication delays...
Nasdaq GlobeNewswire
12/05/2024

Transactions in Zealand Pharma shares and/or related securities by persons…

Company announcement – No. 25 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 12, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities...
Nasdaq GlobeNewswire
12/05/2024

ZINZINO AB (PUBL): Zinzino acquires assets in Xeliss - strategic reinforcement…

A visionary mindset, a tech-first approach, test-based nutrition at the cellular level, and a strong position to take advantage of current trends will shape the foundation of the partnership with Xellis. Since the acquisition of VMA Life in 2020, Enhanzz in 2022, and the strategic cooperation with ACN at the start of 2024, Zinzino has been looking for additional powerful investments to maintain its sustainable, profitable growth, strengthen its distribution power, expand into new markets, and…
PR Newswire
12/05/2024

Photocure Partner Asieris announces New Drug Application acceptance for…

The Asieris media release states: "APL-1702 is a first-in-class, non-surgical treatment for cervical HSIL with its efficacy proven in an international phase III trial. It heralds a potential paradigm shift in the treatment of precancerous cervical lesions, with the clinical focus moving from excision to long-term disease management. Emphasis lies in optimizing the delicate balance between treatment risks and benefits, striving to minimize or delay invasive procedures while effectively…
PR Newswire
12/05/2024

KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value

Dr. Al Fayyadh at Harvard: We Leverage Technology to Tackle Global Health Challenges RIYADH, Saudi Arabia, May11, 2024(GLOBE NEWSWIRE) -- Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at Harvard University. In his address, Dr. Al Fayyadh showcased the KFSH&RC's journey since its...
Nasdaq GlobeNewswire
11/05/2024

BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement

Each Unit consists of one common share in the capital of the Company (each, a "Share") and one whole common share purchase warrant (each, a "Warrant"), whereby each Warrant is convertible into one additional Share at an exercise price of $0.15 until May 10, 2026, being the date that is 24 months from the date of issue. Each Unit consists of one common share in the capital of the Company (each, a " Share ") and one whole common share purchase warrant (each, a "…
PR Newswire
10/05/2024
Altri  Comunicati